Daily-equity-report by Epic Research 11.02.13

download Daily-equity-report by Epic Research 11.02.13

of 4

Transcript of Daily-equity-report by Epic Research 11.02.13

  • 7/29/2019 Daily-equity-report by Epic Research 11.02.13

    1/4

    -=6HEADLINES

    Indian Market

    Indian equity markets were down 0.59%

    Nifty down by 35.30 pts and settle at5903.50

    Sensex down by 114.09 pts at 19466.23

    Bank Nifty down by 78.05 pts at12340.00

    Global Market

    European markets were up with FTSEup by 22.77 closed at 6251 ,CAC up by12.04 closed at 3613 and DAX down by0.03 closed at 7590.

    Dow future was down 3.00 closed at

    13895.00

    WWW.EPICRESEARCH.CO 09752199966

    DAILY EQUITY

    NEWSLETTER11

    THFEBRUARY 2013

    HEADLINES

    M&M Q3 standalone net profit up 26% at

    Rs 836cr

    Sun Pharma Q3 beats forecast, profit up

    32% to Rs 881 cr

    Will invite partners for managed services

    company: Airtel

    Telcos keep removing inactive SIMs;

    26m users lost in Dec

  • 7/29/2019 Daily-equity-report by Epic Research 11.02.13

    2/4

    FIIs and DIIs

    CATEGORY DATE BUY SELL NET

    FII 8-Feb-13 4385.02 2894.2 1490.82

    DII 8-Feb-13 953.3 1662.66 -709.36

    NIFTY DAILY PIVOTS

    IVOT R4 R3 R2 R1 PP S1 S2 S3 S4

    IFTY 6123 6053 5983 5943 5913 5873 5843 5773 5703

    WWW.EPICRESEARCH.CO 09752199966

    MARKETANALYSIS:

    Key benchmark indices edged lower in choppy trade on concerns that PSU disinvestment and reductionof promoter stake to meet the Securities & Exchange Board of India (Sebi) mandated minimum publicshareholding of 25% for private companies and 10% for state-run firms will result in supply of equity

    in the market over the next few months.BSE Sensex was down 114.09 points or 0.58% to 19,466.23.S&P CNX Nifty was down 44.35 points or 0.75% to 5,894.45.

    Among the 30-share Sensex pack, 23 stocks declined while the rest of them rose.Cadila Healthcare fell 2.63% on weak Q3 results. The company's consolidated net profit declined

    31.03% to Rs 102.91 crore on 15.67% rise in total income to Rs 1621.17 crore in Q3 December 2012

    over Q3 December 2011. Sun Pharmaceutical Industries dropped 0.9% on profit taking after strong Q3results. The stock had witnessed pre-result rally on expectations of strong results. Cement major ACC

    declined 3.19%. Ambuja Cements slumped 5.12% IT stocks rose on weak rupee. The rupee droppedfor third session today, 8 February 2013. Infosys gained 0.01%, with the stock reversing intraday

    losses.

    STOCKS TO WATCH

    ALLAHBAD BANK AUROBINDO PHARMA TCS PFC

    SCRIPS IN BAN PERIOD

    WELCORP

    PUNJLYOD

    SUZLON

    IRB

  • 7/29/2019 Daily-equity-report by Epic Research 11.02.13

    3/4

    WWW.EPICRESEARCH.CO 09752199966

    .

    EXPERT OPINION

    NIFTY

    Nifty looks Bearish

    Strategy: Sell on rise

    Support:5860

    Resistance: 5950

    BANK NIFTY

    Bank Nifty looks Bearish

    Strategy: Sell on rise

    Support:12280

    Resistance:12400

    .0

    GAINERSANDLOOSERS

    PREVIOUSPERFORMANCE

    TYPE SCRIP B/S RESULT

    CASHALLAHBAD

    BANKS SL TRIGERRE

    CASHAPOLLO

    TYREB TARGET HIT

    FUTURETATA

    MOTORSS

    NOT

    EXECUTED

    FUTUREARBINDO

    PHARMAS TARGET HIT

    UPCOMINGRESULTS

    BRITANNIA

    HEXAWARE

    JAIPRAKASHASSOCIATES

    TATAPOWER

    DAILY NIFTY GAINERS

    SCRIPS RATE VOL.

    (000)

    PR.

    CLOSE

    NET

    CHAN

    GE

    %

    CHANG

    E

    TCS 1422.60 3486.81 1387.15 35.45 2.56

    Wipro 412.40 1064.71 405.70 6.70 1.65

    BHEL 208.75 3394.24 206.00 2.75 1.33

    HDFC

    Bank650.05 4706.66 641.50 8.55 1.33

    L & T 1511.10 894.21 1496.40 14.70 0.98

    DAILY NIFTY LOOSERS

    SCRIPS RATE VOL.

    (000)

    PR.

    CLOSE

    NET

    CHAN

    GE

    %

    CHAN

    GE

    Ambuja

    Cement189.55 6564.25 199.95 -10.4 -5.2

    Cipla 380.65 4826.51 394.1 -13.45 -3.41

    Hindalco 109.7 15775.97 113.35 -3.65 -3.22

    ACC 1303.75 651.48 1344.3 -40.55 -3.02

    Sesa Goa 169.85 1613.89 174.4 -4.55 -2.61

  • 7/29/2019 Daily-equity-report by Epic Research 11.02.13

    4/4

    .

    MARKET CALLS

    CASH

    SCRIPS ACTION LEVEL 1ST

    TARGET 2ND

    TARGET STOP LOSS

    ANDHRA BANK SELL 102.00 101.00 99.50 103.00

    STERLITE SELL 100.60 99.60 98.10 101.60

    FUTURE

    SCRIPS ACTION LEVEL 1ST

    TARGET 2ND

    TARGET STOP LOSS

    ALLAHBAD BANK SELL 147.00 146.00 144.50 148.00

    AUROBINDO

    PHARMA SELL 181.20 180.20 179.20 182.20

    DisclaimerThe information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any

    responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

    Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on

    sources that we consider reliable.

    This material is for personal information and based upon it & takes no responsibility

    The information given herein should be treated as only factor, while making investment decision. The report does not provide individually

    tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and

    encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on

    the information given in this report, which is in violation of rules and regulations of NSE and BSE.

    The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all

    estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks

    recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views

    expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of

    the information is the acceptance of this disclaimer.

    All Rights Reserved.Investment in equity & bullion market has its own risks.

    We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any

    financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to

    buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls

    or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious

    Legal Actions can be taken.